Answer
It is licensed as monotherapy for chronic lymphocytic leukaemia and for relapsed or refractory mantle cell lymphoma previously treated with a BTK inhibitor.
Sources for this answer
- Jaypirca 50mg, 100mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.